Steve Schonfeld’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.26M Buy
+27,428
New +$1.32M ﹤0.01% 1425
2026
Q2
– Sell
-19,552
Closed -$630K – 3034
2026
Q1
$630K Buy
+19,552
New +$724K ﹤0.01% 1286
2025
Q4
– Sell
-16,140
Closed -$554K – 2616
2025
Q3
$554K Sell
16,140
-10,514
-39% -$302K ﹤0.01% 1648
2025
Q2
$720K Sell
26,654
-30,176
-53% -$874K ﹤0.01% 1425
2025
Q1
$1.69M Buy
56,830
+10,010
+21% +$382K 0.01% 1034
2024
Q4
$1.85M Buy
46,820
+31,221
+200% +$1.18M 0.01% 868
2024
Q3
$531K Sell
15,599
-31,195
-67% -$878K ﹤0.01% 1407
2024
Q2
$1.01M Sell
46,794
-42,450
-48% -$893K 0.01% 1201
2024
Q1
$1.98M Sell
89,244
-6,252
-7% -$153K 0.01% 997
2023
Q4
$2.63M Buy
95,496
+296
+0.3% +$7.14K 0.02% 710
2023
Q3
$2.13M Buy
95,200
+7,734
+9% +$199K 0.02% 811
2023
Q2
$2.23M Buy
87,466
+18,297
+26% +$444K 0.02% 718
2023
Q1
$1.54M Sell
69,169
-9,131
-12% -$221K 0.01% 777
2022
Q4
$1.86M Buy
+78,300
New +$1.82M 0.02% 850
2022
Q2
– Sell
-18,800
Closed -$518K – 3024
2022
Q1
$518K Buy
+18,800
New +$538K ﹤0.01% 1344

Other funds holding VCYT

Steve Schonfeld's VCYT Position: Q3 2026 in Review

Steve Schonfeld opened a new position in Veracyte (VCYT) in Q3 2026: 27,428 shares worth $1.26M. The stake represents ﹤0.01% of the portfolio and ranks #1425 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in VCYT as recently as Q1 2026.

Steve Schonfeld first reported a position in VCYT in Q1 2022 and has held it in 15 quarters since. The position peaked at $2.63M in Q4 2023. 383 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

  • Steve Schonfeld held 27,428 shares of Veracyte worth $1.26M as of Q3 2026.
  • Veracyte was a new Steve Schonfeld position in Q3 2026.
  • Veracyte made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #1425 holding.
  • Steve Schonfeld first reported a position in Veracyte in Q1 2022 and has held it in 15 quarters since.
  • Steve Schonfeld's Veracyte position peaked at $2.63M in Q4 2023.
  • 383 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.